READ THIS GOOD REVIEW OF BIOTECH IPOs SINCE 2000. Liquidity drives VC investments. There are two main liquidity paths: IPOs, and M&A. Without liquidity events, investors cannot get their ROI. Unfortunately the IPO exit has been miserable for biotech, and the slack has not been taken up substantially by acquisitions. ”
“While these trends tend to be cyclic, the current downturn has a very chilling effect on investments.
http://lnkd.in/tvw_Kb
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022